These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23347301)

  • 1. Cardiovascular aspects of psoriasis: an updated review.
    Pietrzak A; Bartosińska J; Chodorowska G; Szepietowski JC; Paluszkiewicz P; Schwartz RA
    Int J Dermatol; 2013 Feb; 52(2):153-62. PubMed ID: 23347301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
    Alexandroff AB; Pauriah M; Camp RD; Lang CC; Struthers AD; Armstrong DJ
    Br J Dermatol; 2009 Jul; 161(1):1-7. PubMed ID: 19500102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular aspects of psoriasis: an updated review.
    Ahlehoff O; Gislason G; Hansen PR
    Int J Dermatol; 2014 Jun; 53(6):e337. PubMed ID: 24673198
    [No Abstract]   [Full Text] [Related]  

  • 5. The concept of psoriasis as a systemic inflammation: implications for disease management.
    Reich K
    J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic cardiovascular involvement in psoriasis: a systematic review.
    Mosca S; Gargiulo P; Balato N; Di Costanzo L; Parente A; Paolillo S; Ayala F; Trimarco B; Crea F; Perrone-Filardi P
    Int J Cardiol; 2015 Jan; 178():191-9. PubMed ID: 25464252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study.
    Ahlehoff O; Skov L; Gislason G; Lindhardsen J; Kristensen SL; Iversen L; Lasthein S; Gniadecki R; Dam TN; Torp-Pedersen C; Hansen PR
    J Intern Med; 2013 Feb; 273(2):197-204. PubMed ID: 22963528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psoriasis and atherothrombotic disease].
    Ahlehoff O; Gislason GH; Skov L; Hansen PR
    Ugeskr Laeger; 2010 Jun; 172(26):1983-6. PubMed ID: 20654288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis.
    Armstrong AW; Voyles SV; Armstrong EJ; Fuller EN; Rutledge JC
    Exp Dermatol; 2011 Jul; 20(7):544-9. PubMed ID: 21692858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.
    Boehncke WH; Boehncke S
    Curr Rheumatol Rep; 2012 Aug; 14(4):343-8. PubMed ID: 22562431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease.
    Torres T; Sales R; Vasconcelos C; Martins da Silva B; Selores M
    J Dermatol; 2013 Nov; 40(11):923-6. PubMed ID: 24128349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors.
    Miller IM; Ellervik C; Yazdanyar S; Jemec GB
    J Am Acad Dermatol; 2013 Dec; 69(6):1014-24. PubMed ID: 24238156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
    Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
    J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mechanisms shared between psoriasis and cardiovascular disease.
    Ghazizadeh R; Shimizu H; Tosa M; Ghazizadeh M
    Int J Med Sci; 2010 Aug; 7(5):284-9. PubMed ID: 20827428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis and cardiovascular comorbidities with emphasis in Asia.
    Chu TW; Tsai TF
    G Ital Dermatol Venereol; 2012 Apr; 147(2):189-202. PubMed ID: 22481582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Involvement in Psoriasis, Diagnosing Subclinical Atherosclerosis, Effects of Biological and Non-Biological Therapy: A Literature Review.
    Valaiyaduppu Subas S; Mishra V; Busa V; Antony I; Marudhai S; Patel M; Cancarevic I
    Cureus; 2020 Oct; 12(10):e11173. PubMed ID: 33262910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
    Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
    J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk?
    Sunbul M; Agirbasli M
    Curr Pharm Des; 2014; 20(4):529-35. PubMed ID: 23565636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk and psoriasis: beyond the traditional risk factors.
    Coumbe AG; Pritzker MR; Duprez DA
    Am J Med; 2014 Jan; 127(1):12-8. PubMed ID: 24161194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.